Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $1.29, $0.22 better than the analyst estimate of $1.07. Revenue for the quarter came in at $295.6 million versus the consensus estimate of $292.15 million.

GUIDANCE:

Medpace Holdings sees FY2021 EPS of $4.66-$4.77, versus the consensus of $4.45. Medpace Holdings sees FY2021 revenue of $1.135-1.145 billion, versus the consensus of $1.14 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.